128 related articles for article (PubMed ID: 21195698)
21. Detection of a polymorphic 27 bp insertion/deletion in exon 4 of the canine calcitonin/calcitonin gene-related peptide gene I (CALCA).
Wende S; Krempler A; Brenig B
Anim Genet; 2000 Jun; 31(3):238-9. PubMed ID: 10895326
[No Abstract] [Full Text] [Related]
22. Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression.
Buervenich S; Xiang F; Sydow O; Jönsson EG; Sedvall GC; Anvret M; Olson L
Hum Mutat; 2001 May; 17(5):435-6. PubMed ID: 11317366
[TBL] [Abstract][Full Text] [Related]
23. Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.
Ismail EA; El-Mogy MI; Mohamed DS; El-Farrash RA
J Pediatr Hematol Oncol; 2011 Oct; 33(7):534-42. PubMed ID: 21423046
[TBL] [Abstract][Full Text] [Related]
24. Periodontal inflammation is related to increased serum calcitonin gene-related peptide levels in patients with chronic migraine.
Leira Y; Ameijeira P; Domínguez C; López-Arias E; Ávila-Gómez P; Pérez-Mato M; Sobrino T; Campos F; D'Aiuto F; Leira R; Blanco J
J Periodontol; 2019 Oct; 90(10):1088-1095. PubMed ID: 31070784
[TBL] [Abstract][Full Text] [Related]
25. Association of a Notch 3 gene polymorphism with migraine susceptibility.
Menon S; Cox HC; Kuwahata M; Quinlan S; MacMillan JC; Haupt LM; Lea RA; Griffiths LR
Cephalalgia; 2011 Feb; 31(3):264-70. PubMed ID: 20813781
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study.
Rubino E; Boschi S; Giorgio E; Pozzi E; Marcinnò A; Gallo E; Roveta F; Grassini A; Brusco A; Rainero I
Neurobiol Pain; 2022; 11():100089. PubMed ID: 35445161
[TBL] [Abstract][Full Text] [Related]
27. No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility.
Colson NJ; Lea RA; Quinlan S; Griffiths LR
BMC Med Genet; 2006 Feb; 7():12. PubMed ID: 16504171
[TBL] [Abstract][Full Text] [Related]
28. The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation.
Huebner AK; Keller J; Catala-Lehnen P; Perkovic S; Streichert T; Emeson RB; Amling M; Schinke T
Arch Biochem Biophys; 2008 May; 473(2):210-7. PubMed ID: 18307972
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of RAMP1 gene in migraine: an exploratory analysis.
Wan D; Hou L; Zhang X; Han X; Chen M; Tang W; Liu R; Dong Z; Yu S
J Headache Pain; 2015; 16():90. PubMed ID: 26501962
[TBL] [Abstract][Full Text] [Related]
30. MiR-30a relieves migraine by degrading CALCA.
Zhai Y; Zhu YY
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2022-2028. PubMed ID: 29687858
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of 5' and 3' processing sites as well as intron and exon sequences in calcitonin exon recognition.
Zandberg H; Moen TC; Baas PD
Nucleic Acids Res; 1995 Jan; 23(2):248-55. PubMed ID: 7862529
[TBL] [Abstract][Full Text] [Related]
32. Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine.
Guo S; Christensen AF; Liu ML; Janjooa BN; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):114-124. PubMed ID: 26994300
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
34. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
35. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
[TBL] [Abstract][Full Text] [Related]
36. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
37. Cox-2 gene variants in migraine.
Dasdemir S; Cetinkaya Y; Gencer M; Ozkok E; Aydin M; Cakmakoglu B
Gene; 2013 Apr; 518(2):292-5. PubMed ID: 23357220
[TBL] [Abstract][Full Text] [Related]
38. The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing.
Lou H; Cote GJ; Gagel RF
Mol Endocrinol; 1994 Dec; 8(12):1618-26. PubMed ID: 7535892
[TBL] [Abstract][Full Text] [Related]
39. Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study.
Palmirotta R; Barbanti P; Ludovici G; De Marchis ML; Ialongo C; Egeo G; Aurilia C; Fofi L; Abete P; Spila A; Ferroni P; Della-Morte D; Guadagni F
Pharmacogenomics; 2014 Feb; 15(2):147-55. PubMed ID: 24444405
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
